Enhanced expression of CYP1B1 in Escherichia coli

Toxicology

Volumn 144, Issue 1-3, 2000, Pages 211-219

  Jansson, Ingela ^a   Stoilov, Ivaylo ^a   Sarfarazi, Mansoor ^a   Schenkman, John B ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Aminolevulinic acid; CYP1B1; Heme precursor; P450 heterologous expression

Indexed keywords

AMINOLEVULINIC ACID; CYTOCHROME P450 1B1; HEMOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ENZYME PURIFICATION; ESCHERICHIA COLI; HEME SYNTHESIS; MOLECULAR CLONING; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINOLEVULINIC ACID; ARYL HYDROCARBON HYDROXYLASES; CLONING, MOLECULAR; CYTOCHROME P-450 ENZYME SYSTEM; DNA FRAGMENTATION; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ESCHERICHIA COLI;

EID: 0034599999     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(99)00209-7     Document Type: Article

References (24)

1. Allen L., Burion H.M., Braley A.E. A new concept of development of anterior chamber angle: its relationship to developmental glaucoma and other structural anomalies. Arch. Ophthalmol. 53:1955;783-798.
2. Anderson D.R. The development of the trabecular meshwork and its abnormality in primary infantile glaucoma. Trans. Am. Ophthalmol. Soc. 79:1981;458-485.
3. Barkan O. Pathogenesis of congenital glaucoma. Am. J. Ophthalmol. 40:1955;1-11.
4. Bauer S., Shiloach J. Maximal exponential growth rate and yield of E. coli obtainable in a bench-scale fermentor. Biotechnol. Bioeng. 16:1974;933-941.
5. Bredt D.S., Hwang P.M., Glatt C.E., Lowenstein C., Reed R.R., Snyder S.H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 351:1991;714-718.
6. Christou M., Savas U., Schroeder S., Shen X., Thompson T., Gould M.N., Jefcoate C.R. Cytochrome CYP1A1 and CYP1B1 in the rat mammary gland: cell-specific expression and regulation by polycyclic aromatic hydrocarbons and hormones. Mol. Cell. Endocrinol. 115:1995;41-50.
7. Fisher C.W., Caudle D.L., Martin-Wixtrom C., Quattrochi L.C., Tukey R.H., Waterman M.R., Estabrook R.W. High-level expression of functional human cytochrome- P450 1A2 in Escherichia coli. FASEB J. 6:1992;759-764.
8. Fisher C.W., Shet M.S., Caudle D.L., Martin-Wixtrom C.A., Estabrook R.W. High-level expression in Escherichia coli of enzymatically active fusion proteins containing the domains of mammalian cytochromes P450 and NADPH-P450 reductase flavoprotein. Proc. Natl. Acad. Sci. USA. 89:1992;10817-10821.
9. Gillam E.M.K., Guo Z., Martin M.V., Jenkins C.M.J., Guengerich F.P. Expression of cytochrome P450 2D6 in Escherichia coli: purification, and spectral and catalytic characterization. Arch. Biochem. Biophys. 319:1995;540-550.
10. Johnson E.R., Waterman M.R. Abelson J.N., Simon M.I. Methods in Enzymology. 272:1996;Academic Press, New York.
11. Kupfer C., Kaiser-Kupfer M. Observations on the development of the anterior chamber angle with reference to the pathogenesis of congenital glaucoma. Am. J. Ophthalmol. 88:1979;423-426.
12. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
13. Nebert D. Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol. Endocrinol. 5:1991;1203-1214.
14. Ohashi K., Ruan K., Kulmacz R., Wu K., Wang L. Primary structure of human thromboxane synthase determined from the cDNA sequence. J. Biol. Chem. 267:1992;789-793.
15. Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties. J. Biol. Chem. 239:1964;2379-2385.
16. Richardson T.H., Jung F., Griffin K.J., Wester M., Raucey J.L., Kemper B., Bornheim L.M., Hassett C., Omienski C.J., Johnnson E.F. A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli. Arch. Biochem. Biophys. 323:1995;87-96.
17. Sandhu P., Guo Z., Baba T., Martin M., Tukey R., Guengerich F. Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme. Arch. Biochem. Biophys. 309:1994;168-177.
18. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
19. Savas U., Bhattacharyya K.K., Christou M., Alexander D.L., Jefcoate C.R. Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. J. Biol. Chem. 269:1994;14905-14911.
20. Schenkman J.B. The fate of xenobiotics in the body. Arinç E., Schenkman J.B., Hodgson E. Molecular and Applied Aspects of Oxidative Drug Metabolizing Enzymes. 303:1999;1-20 Plenum, New York. Nato ASI Series A: Life Sciences.
21. Schenkman J.B., Jansson I. Spectral analysis of cytochrome P450. Phillips I.R., Shephard E.A. Cytochrome P450 Protocols. Methods in Molecular Biology. 107:1998;25-33 Humana Press, Totowa, NJ.
22. Shimada T., Wunsch R.M., Hanna I.H., Sutter T.R., Guengerich F.P., Gillam E.M.J. Recombinant human cytochrome P450 1B1 expression in Escherichia coli. Arch. Biochem. Biophys. 357:1998;111-120.
23. Stoilov I., Akarsu A.N., Sarfarazi M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum. Mol. Genet. 6:1997;641-647.
24. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.